Q1 2025

Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001193125-24-258672

Q1 2025 · 10-Q

Revenue

$0.00

— vs Q1 2024

Net Income

-$5.06M

N/M vs Q1 2024

EPS Diluted

-$0.18

N/M vs Q1 2024

Operating Income-$5,791,000N/M

Operating Cash Flow

Same quarter

Metric	Q1 2025	Q1 2024	Q1 2023	Q1 2022
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$5.06M	-$5.95M	-$5.09M	-$5.05M
EPS Diluted	-$0.18	-$3.05	-$7.98	-$0.62

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR